SCHEMBL11030508

SCHEMBL11030508

Cc1ccccc1C1C(=O)NC(C)(C)C1=O

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.44
CRBN Q96SW2 1/20 0.44
ALDH1A1 P00352 6/20 0.39
GSK3B P49841 2/20 0.39
BACE1 P56817 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PBRM1 Q86U86 2/20 0.38
TNKS2 Q9H2K2 2/20 0.38
HTR2C P28335 2/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HSD17B10 Q99714 2/20 0.35
ALOX15 P16050 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8555344 0.78 CACNB4 (0.38) GAALMNAMAPTMAPK1
SCHEMBL11024284 0.77 LMNA (0.41) DDB1CRBNALDH1A1L3MBTL1LMNA
SCHEMBL9802951 0.74 DDB1 (0.49) DDB1CRBNALDH1A1GSK3BBACE1
SCHEMBL342054 0.74 DDB1 (0.39) DDB1CRBNGSK3BNPSR1HTR2C
SCHEMBL11686278 0.72 DDB1 (0.44) DDB1CRBNALDH1A1GSK3BBACE1
SCHEMBL7142077 0.72 GRIN2D (0.35) ALDH1A1NPSR1HTR2CMAPT
SCHEMBL7000246 0.72 HSD11B1 (0.36) ALDH1A1GAAKDM4E
SCHEMBL5234343 0.71 CES1 (0.34) PBRM1GAALMNA
SCHEMBL11025101 0.70 KMT2A (0.44) ALDH1A1GSK3BPBRM1HTR2CGAA
SCHEMBL11807034 0.70 KMT2A (0.53) ALDH1A1PBRM1TNKS2GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106905215-B Process for preparing 1-H-pyrrolidine-2, 4-dione derivatives 拜耳知识产权有限责任公司 2021-10-01 CN disclosed
EP-3372580-B1 METHOD FOR THE PREPARATION OF 1-H-PYRROLIDIN-2,4-DIONE-DERIVATIVES BAYER CROPSCIENCE AG (DE) 2020-07-22 EP disclosed
EP-3372580-A1 METHOD FOR THE PREPARATION OF 1-H-PYRROLIDIN-2,4-DIONE-DERIVATIVES Bayer CropScience Aktiengesellschaft (DE) 2018-09-12 EP disclosed
EP-2668158-B1 METHOD FOR PRODUCING 1-H-PYRROLIDINE-2,4-DIONE DERIVATIVES BAYER IP GMBH (DE) 2018-06-27 EP disclosed
US-9272997-B2 Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-03-01 US disclosed
US-20140371468-A1 Process for the Preparation of 1-H-pyrrolidine-2,4-dione Derivatives BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2014-12-18 US disclosed
US-8859782-B2 Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives BAYER CROPSCIENCE AG (DE) 2014-10-14 US disclosed
EP-2668158-A1 METHOD FOR PRODUCING 1-H-PYRROLIDINE-2,4-DIONE DERIVATIVES Bayer Intellectual Property GmbH (DE) 2013-12-04 EP disclosed
WO-2012101047-A1 METHOD FOR PRODUCING 1-H-PYRROLIDINE-2,4-DIONE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2012-08-02 WO disclosed
US-20120190865-A1 Process for the Preparation of 1-H-pyrrolidine-2,4-dione Derivatives BAYER CROPSCIENCE AG (DE) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190865-A1 Process for the Preparation of 1-H-pyrrolidine-2,4-dione Derivatives DHPS, HPD, DOHH DDB1 1467/4885CRBN 1806/4885ALDH1A1 318/4885
US-20140371468-A1 Process for the Preparation of 1-H-pyrrolidine-2,4-dione Derivatives DHPS, HPD, DOHH DDB1 1467/4885CRBN 1806/4885ALDH1A1 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.